Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO Chris Viehbacher comments on 2012 results and outlook for 2013.
Click to watch the video: http://bit.ly/XkZjhU
Topics covered in the interview include:
- 2012 Results
- Emerging Markets
- Diabetes franchise
- R&D Pipeline
- Animal Health
- Capital Allocation
- Cost savings
- 2013 Guidance
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (SAN) and in New York (SNY).
Company website: www.sanofi.com